Merck KGaA CFO on Sales Forecast Cut, China Competition

The video discusses the impact of the euro's strength on sales forecasts, highlighting currency fluctuations and their effects on the top and bottom lines. It examines the risks in the immuno-oncology market, emphasizing the importance of strategic pipeline development. The challenges faced by the Material Sciences division due to Chinese competition are addressed, along with management changes aimed at maintaining technology leadership. Finally, the video analyzes recent share price declines, suggesting market overreaction and focusing on long-term business stabilization strategies.

How does the company plan to manage currency fluctuations?

What are the expectations for the company's pipeline in 2017?

What is the significance of the management changes in the Material Sciences division?